glucose breath test
Recently Published Documents


TOTAL DOCUMENTS

49
(FIVE YEARS 7)

H-INDEX

9
(FIVE YEARS 1)

Nutrients ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 304
Author(s):  
Osnat Kaniel ◽  
Shiri Sherf-Dagan ◽  
Amir Szold ◽  
Peter Langer ◽  
Boris Khalfin ◽  
...  

One anastomosis gastric bypass (OAGB) is an emerging bariatric procedure, yet data on its effect on the gastrointestinal tract are lacking. This study sought to evaluate the incidence of small-intestinal bacterial overgrowth (SIBO) following OAGB; explore its effect on nutritional, gastrointestinal, and weight outcomes; and assess post-OABG occurrence of pancreatic exocrine insufficiency (PEI) and altered gut microbiota composition. A prospective pilot cohort study of patients who underwent primary-OAGB surgery is here reported. The pre-surgical and 6-months-post-surgery measurements included anthropometrics, glucose breath-tests, biochemical tests, gastrointestinal symptoms, quality-of-life, dietary intake, and fecal sample collection. Thirty-two patients (50% females, 44.5 ± 12.3 years) participated in this study, and 29 attended the 6-month follow-up visit. The mean excess weight loss at 6 months post-OAGB was 67.8 ± 21.2%. The glucose breath-test was negative in all pre-surgery and positive in 37.0% at 6 months (p = 0.004). Positive glucose breath-test was associated with lower reported dietary intake and folate levels and higher vitamin A deficiency rates (p ≤ 0.036). Fecal elastase-1 test (FE1) was negative for all pre-surgery and positive in 26.1% at 6 months (p = 0.500). Both alpha and beta diversity decreased at 6 months post-surgery compared to pre-surgery (p ≤ 0.026). Relatively high incidences of SIBO and PEI were observed at 6 months post-OAGB, which may explain some gastrointestinal symptoms and nutritional deficiencies.


2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1149-1149
Author(s):  
Abrar Turki ◽  
Sylvia Stockler ◽  
Sandra Sirrs ◽  
Ramona Salvarinova ◽  
Rajavel Elango

Abstract Objectives The objectives of the current study were: 1) to establish the use of ,13C-Glucose Breath Test (,13C-GBT) and its oxidation to ,13CO2 as a minimally invasive technique to examine in vivo glucose oxidation in healthy adults, and 2) to measure the utilization of uncooked cornstarch (UCCS) and Glycosade® in patients with glycogen storage disease type Ia (GSD-Ia) and healthy controls using ,13C-GBT, based on the natural enrichment of ,13C in UCCS and Glycosade®. Methods Experiment 1- Ten healthy adults (22 – 33y) underwent ,13C-GBT protocols twice as a proof-of-principle, once without oral isotope dose (only D-glucose 75 g/d) and once with isotope (D-glucose 75 g/d + U-,13C-glucose 75 mg/d). Breath samples were collected at baseline and every 20 min for 240 min to measure ,13CO2. Experiment 2- Two patients (12 and 28y) with GSD-Ia and five healthy controls (10 – 32y) underwent ,13C-GBT protocols twice. Subjects received UCCS or Glycosade® orally (based on their current prescribed dose 42 – 100 g) after a 4 hour fast according to GSD-Ia fasting tolerance. Breath samples were collected at baseline and every 30 min for 240 min. ,13CO2 oxidation of glucose from UCCS and Glycosade® were measured using an isotope ratio mass spectrometer and compared using a paired t-test. Blood glucose was measured using a glucometer hourly to test hypoglycemia (≤3.4 mmol/L). Results Results 1- The mean rate of ,13CO2 in all healthy adults from D-glucose without U-,13C-glucose 0.435 ± 0.162 was significantly lower than the mean rate of ,13CO2 in the same group with U-,13C-glucose 3.518 ± 0.988. The peak occurred at 200 minutes in all healthy adults without and with U-,13C-glucose. Results 2- Glucose oxidation from Glycosade® was lower than glucose oxidation from UCCS in the 12y GSD-Ia. Glucose oxidation from UCCS and Glycosade® remained the same in the 28y GSD-Ia. However, oxidation of glucose by the 28y GSD-Ia for both starches displayed a higher rate, compared to age matched controls. Conclusions Our results show that the minimally invasive,13C-GBT test over 4 hours can be useful to examine glucose metabolism from various exogenous carbohydrate sources in GSD. Future studies are needed to use ,13C-GBT in response to different doses to determine optimal glucose management in GSD patients. Funding Sources Saudi Arabian Cultural Bureau, Ottawa and BC Children's Hospital Research Institute.


2019 ◽  
Vol 56 (8) ◽  
pp. 923-929 ◽  
Author(s):  
Jorge Maldonado-Hernández ◽  
Azucena Martínez-Basila ◽  
Mario Enrique Rendón-Macías ◽  
Mardia López-Alarcón

RADIOISOTOPES ◽  
2019 ◽  
Vol 68 (2) ◽  
pp. 59-64
Author(s):  
Tomokazu Matsuura ◽  
Hirotaka Ezaki ◽  
Mariko Nakamura ◽  
Yoshihiro Mezaki ◽  
Takahiro Masaki

2018 ◽  
Vol 154 (6) ◽  
pp. S-854
Author(s):  
Richard W. McCallum ◽  
Antonio Mendoza-Ladd ◽  
Mingtao Zeng ◽  
Diana Diaz-Arévalo ◽  
Elisa Morales ◽  
...  

2017 ◽  
Vol 152 (5) ◽  
pp. S413 ◽  
Author(s):  
Lavanya Viswanathan ◽  
Sebastian Larion ◽  
Nicole Shaffer ◽  
Amol Sharma ◽  
Satish S. Rao

Sign in / Sign up

Export Citation Format

Share Document